C4 Therapeutics has unveiled an expanded DNA-encoded library (DEL) integrated into its TORPEDO® platform, enhancing its ability to rapidly identify molecular glue degraders for targeted protein degradation. This new DEL leverages C4T's cereblon-binding ligand library and has already produced promising hits against high-value targets within four months, accelerating drug discovery efforts. The technology supports C4T's focus on developing treatments for inflammation, neuroinflammation, and neurodegenerative diseases, with ongoing clinical advancement of cemsidomide. The company plans to further explore this platform for internal projects and partnerships, aiming to transform undruggable targets into druggable ones.
C4 Therapeutics' platform expansion is the subject, with Pluang's Health sector data providing market context. As of Oct 29, 2026 17:11 WIB, 86 of 150 Health-sector US stocks rose and 57 fell. Notable movers include IOVA at USD 16.12 with a +8.85% change, BFLY at USD 8.32 up +6.53%, and NUWE at USD 5.87 with a +5.48% change.
Dimensional Fund Advisors Ltd. disclosed holding a 5.07% stake in Vesuvius PLC ordinary shares as of October 28, 2026. The disclosure follows regulatory requirements under the Takeover Code, indicating significant interest in the company. Dimensional...
Lulu's Fashion Lounge Holdings, Inc. announced it will report its third quarter 2026 financial results on November 12, 2026, after market close. The company will host a live webcast and conference call for investors at 5:00 p.m. Eastern Time the same...
Katapult Holdings, a technology-driven platform serving nonprime consumers, announced it will release its third quarter 2026 financial results on November 12, 2026, before the market opens. The company will hold a conference call and webcast at 8:00 ...
RadNet, Inc. announced it will hold a conference call on November 9, 2026, at 7:30 a.m. Pacific Time to discuss its third quarter financial results. Investors can join via phone or webcast, with a replay available afterward. This call provides insigh...
Westlake Pipe & Fittings has finished building a new 190,000 sq ft molecular-oriented PVC (PVCO) pipe manufacturing plant in Wichita Falls, Texas. This expansion increases Westlake's North American capacity for advanced PVCO pipes, known for superior...
